Liver X receptor alpha ensures blood-brain barrier function by suppressing SNAI2

Cell Death Dis. 2023 Nov 28;14(11):781. doi: 10.1038/s41419-023-06316-8.

Abstract

In Alzheimer's disease (AD) more than 50% of the patients are affected by capillary cerebral amyloid-angiopathy (capCAA), which is characterized by localized hypoxia, neuro-inflammation and loss of blood-brain barrier (BBB) function. Moreover, AD patients with or without capCAA display increased vessel number, indicating a reactivation of the angiogenic program. The molecular mechanism(s) responsible for BBB dysfunction and angiogenesis in capCAA is still unclear, preventing a full understanding of disease pathophysiology. The Liver X receptor (LXR) family, consisting of LXRα and LXRβ, was reported to inhibit angiogenesis and particularly LXRα was shown to secure BBB stability, suggesting a major role in vascular function. In this study, we unravel the regulatory mechanism exerted by LXRα to preserve BBB integrity in human brain endothelial cells (BECs) and investigate its role during pathological conditions. We report that LXRα ensures BECs identity via constitutive inhibition of the transcription factor SNAI2. Accordingly, deletion of brain endothelial LXRα is associated with impaired DLL4-NOTCH signalling, a critical signalling pathway involved in vessel sprouting. A similar response was observed when BECs were exposed to hypoxia, with concomitant LXRα decrease and SNAI2 increase. In support of our cell-based observations, we report a general increase in vascular SNAI2 in the occipital cortex of AD patients with and without capCAA. Importantly, SNAI2 strongly associated with vascular amyloid-beta deposition and angiopoietin-like 4, a marker for hypoxia. In hypoxic capCAA vessels, the expression of LXRα may decrease leading to an increased expression of SNAI2, and consequently BECs de-differentiation and sprouting. Our findings indicate that LXRα is essential for BECs identity, thereby securing BBB stability and preventing aberrant angiogenesis. These results uncover a novel molecular pathway essential for BBB identity and vascular homeostasis providing new insights on the vascular pathology affecting AD patients.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alzheimer Disease* / metabolism
  • Amyloid beta-Peptides / metabolism
  • Blood-Brain Barrier / metabolism
  • Cerebral Amyloid Angiopathy* / complications
  • Cerebral Amyloid Angiopathy* / metabolism
  • Cerebral Amyloid Angiopathy* / pathology
  • Endothelial Cells / metabolism
  • Humans
  • Hypoxia / metabolism
  • Liver X Receptors / genetics
  • Liver X Receptors / metabolism
  • Snail Family Transcription Factors / genetics
  • Snail Family Transcription Factors / metabolism

Substances

  • Amyloid beta-Peptides
  • Liver X Receptors
  • SNAI2 protein, human
  • Snail Family Transcription Factors
  • NR1H3 protein, human